Ruth H Strasser Selected Research

Ruth H Strasser Research Topics

Disease

21	Myocardial Infarction 12/2021 - 05/2002
14	Infarction (Infarctions) 12/2021 - 08/2002
9	Heart Failure 12/2021 - 11/2007
9	Ischemia 01/2015 - 08/2002
8	Cardiogenic Shock 03/2020 - 03/2007
7	Atherosclerotic Plaque (Atheroma) 05/2015 - 01/2005
6	Hypertrophy 12/2017 - 05/2002
6	Hypoxia (Hypoxemia) 04/2014 - 01/2008
5	Thrombosis (Thrombus) 01/2018 - 05/2004
5	Shock 12/2016 - 02/2010
4	Inflammation (Inflammations) 01/2022 - 08/2008
4	Cardiomegaly (Heart Hypertrophy) 01/2020 - 10/2002
4	Cardiomyopathies (Cardiomyopathy) 06/2013 - 02/2006
4	Right Ventricular Hypertrophy 01/2008 - 10/2002
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2017 - 11/2007
3	Atherosclerosis 01/2017 - 10/2005
3	Wounds and Injuries (Trauma) 01/2017 - 03/2007
3	Heart Arrest (Cardiac Arrest) 08/2016 - 06/2006
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2007 - 10/2002
2	Anterior Wall Myocardial Infarction 12/2021 - 05/2003
2	Systolic Heart Failure 12/2021 - 01/2020
2	Body Weight (Weight, Body) 02/2018 - 08/2002
2	Pulmonary Embolism 10/2016 - 08/2010
2	Acute Coronary Syndrome 09/2016 - 02/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2015 - 07/2011
2	Infections 04/2014 - 08/2006
2	Pressure Ulcer (Bedsore) 12/2012 - 03/2007
2	Fibrosis (Cirrhosis) 05/2008 - 01/2008
2	Heart Valve Diseases (Valvular Heart Disease) 10/2007 - 01/2007
2	Parkinson Disease (Parkinson's Disease) 10/2007 - 01/2007
2	Pathologic Constriction (Stenosis) 05/2006 - 05/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Left Ventricular Dysfunction 12/2017
1	False Aneurysm (Pseudoaneurysm) 06/2017

Drug/Important Bio-Agent (IBA)

12	Protein Kinase CIBA 01/2013 - 05/2002
9	IsoenzymesIBA 10/2016 - 05/2002
7	Caveolin 1IBA 01/2020 - 10/2005
6	Protein Isoforms (Isoforms)IBA 01/2013 - 10/2002
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2002
5	Messenger RNA (mRNA)IBA 08/2011 - 10/2002
5	Protein Kinase C-epsilonIBA 11/2007 - 05/2003
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2011
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2011
3	Chromogranin BIBA 01/2020 - 11/2011
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2020 - 01/2017
3	Oxygen (Dioxygen)IBA 03/2017 - 08/2011
3	Ephrin-A1 (Ephrin A1)IBA 01/2017 - 10/2013
3	Simendan (Levosimendan)IBA 09/2016 - 08/2008
3	WortmanninIBA 01/2013 - 03/2010
3	Caspase 3 (Caspase-3)IBA 01/2013 - 01/2006
3	Propidium (Propidium Iodide)IBA 06/2010 - 02/2004
2	Contrast MediaIBA 01/2022 - 06/2013
2	CalciumIBA 01/2020 - 03/2010
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020 - 01/2007
2	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2020 - 02/2009
2	Natriuretic PeptidesIBA 01/2020 - 01/2018
2	Clostridium perfringens epsilon-toxinIBA 01/2018 - 03/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 12/2008
2	Fatty Acid Binding Protein 3IBA 10/2016 - 08/2010
2	Troponin IIBA 10/2016 - 08/2010
2	Fatty Acid-Binding ProteinsIBA 10/2016 - 08/2010
2	Cardiotonic Agents (Cardiac Stimulants)IBA 01/2015 - 01/2013
2	LigandsIBA 12/2014 - 10/2013
2	CatecholaminesIBA 05/2013 - 08/2008
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2013 - 06/2010
2	oxidized low density lipoproteinIBA 09/2011 - 10/2007
2	Glycogen Synthase Kinase 3 betaIBA 06/2010 - 11/2008
2	EnoximoneIBA 03/2010 - 08/2008
2	DNA (Deoxyribonucleic Acid)IBA 03/2010 - 03/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2009 - 01/2007
2	beta Adrenergic ReceptorsIBA 02/2009 - 03/2003
2	chelerythrineIBA 03/2008 - 08/2002
2	EnzymesIBA 11/2007 - 07/2004
2	Dopamine Agonists (Dopamine Agonist)IBA 10/2007 - 01/2007
2	salicylhydroxamic acid (SHAM)IBA 05/2006 - 05/2003
2	isooctyl acrylateIBA 02/2004 - 08/2002
1	C-Reactive ProteinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	ProcalcitoninIBA 01/2022
1	CalpainIBA 12/2021
1	Inositol (Myoinositol)IBA 01/2020
1	Atrial Natriuretic Factor (ANF)IBA 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 02/2018
1	SelectinsIBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	Thrombin FDA Link 06/2017

Therapy/Procedure

14	Therapeutics 12/2021 - 04/2006
7	Ligation 12/2021 - 05/2002
5	Stents 04/2014 - 05/2004
3	Resuscitation 08/2015 - 08/2006
3	Counterpulsation (External Counterpulsation) 04/2015 - 06/2012
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 09/2013 - 02/2010
2	Length of Stay 12/2012 - 03/2007
2	Percutaneous Coronary Intervention 06/2012 - 02/2007
2	Ischemic Postconditioning 06/2010 - 03/2010
2	Catheters 08/2006 - 05/2004
1	Transcatheter Aortic Valve Replacement 01/2022
1	Heart-Assist Devices 03/2020
1	Sutures (Suture) 06/2017
1	Punctures 06/2017